Found: 15
Select item for more details and to access through your institution.
Congress Should Decline Ill-Advised Legislative Proposals Aimed at Evergreening of Pharmaceutical Patent Protection.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 493
- By:
- Publication type:
- Article
ANTIBODY PATENTS: USE OF THE WRITTEN DESCRIPTION AND ENABLEMENT REQUIREMENTS AT THE PATENT & TRADEMARK OFFICE.
- Published in:
- Berkeley Technology Law Journal, 2023, v. 38, n. 1, p. 1, doi. 10.15779/Z385Q4RN0D
- By:
- Publication type:
- Article
RECENT DEVELOPMENTS AFFECTING THE ENFORCEMENT, PROCUREMENT, AND LICENSING OF RESEARCH TOOL PATENTS.
- Published in:
- Berkeley Technology Law Journal, 2008, v. 23, n. 4, p. 1299
- By:
- Publication type:
- Article
IN DEFENSE OF SECONDARY PHARMACEUTICAL PATENTS: A RESPONSE TO THE UN'S GUIDELINES FOR PHARMACEUTICAL PATENT EXAMINATION.
- Published in:
- Indiana Law Review, 2017, v. 50, n. 3, p. 759, doi. 10.18060/4806.1153
- By:
- Publication type:
- Article
Patent Eligibility Post-Myriad: A Reinvigorated Judicial Wildcard of Uncertain Effect.
- Published in:
- 2014
- By:
- Publication type:
- Essay
Bowman v. Monsanto Co.: A Bellwether for the Emerging Issue of Patentable Self-Replicating Technologies and Inadvertent Infringement.
- Published in:
- Missouri Law Review, 2015, v. 80, n. 3, p. 665
- By:
- Publication type:
- Article
Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation.
- Published in:
- Missouri Law Review, 2011, v. 76, n. 3, p. 645
- By:
- Publication type:
- Article
Developments in Synthetic Biology Are Altering the IP Imperatives of Biotechnology.
- Published in:
- Vanderbilt Journal of Entertainment & Technology Law, 2015, v. 17, n. 2, p. 385
- By:
- Publication type:
- Article
ANTIBODY CLAIMS AND THE EVOLUTION OF THE WRITTEN DESCRIPTION/ENABLEMENT REQUIREMENT.
- Published in:
- IDEA: The Intellectual Property Law Review, 2022, v. 63, n. 1, p. 84
- By:
- Publication type:
- Article
THE CRITICAL ROLE OE PATENTS IN THE DEVELOPMENT, COMMERCIALIZATION AND UTILIZATION OF INNOVATIVE GENETIC DIAGNOSTIC TESTS AND PERSONALIZED MEDICINE.
- Published in:
- Journal of Science & Technology Law, 2015, v. 21, n. 2, p. 297
- By:
- Publication type:
- Article
Advances in DNA sequencing lead to patent disputes.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 11, p. 1054, doi. 10.1038/nbt.2407
- By:
- Publication type:
- Article
Debunking the myth that whole-genome sequencing infringes thousands of gene patents.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 3, p. 240, doi. 10.1038/nbt.2146
- By:
- Publication type:
- Article
THE RENEWABLE FUEL STANDARD REIMAGINED: CLEARING A PATH FOR TRULY ADVANCED BIOFUELS.
- Published in:
- UMKC Law Review, 2018, v. 86, n. 4, p. 805
- By:
- Publication type:
- Article
WILL GENE PATENTS DERAIL THE NEXT GENERATION OF GENETIC TECHNOLOGIES?: A REASSESSMENT OF THE EVIDENCE SUGGESTS NOT.
- Published in:
- UMKC Law Review, 2012, v. 80, n. 3, p. 563
- By:
- Publication type:
- Article
THE MAYO FRAMEWORK IS BAD FOR YOUR HEALTH.
- Published in:
- George Mason Law Review, 2016, v. 23, n. 4, p. 901
- By:
- Publication type:
- Article